Goodman Tony has filed 4 insider transactions across 1 company since May 2023.
Most recent transaction: a grant/award of 26510 shares of ADIAL PHARMACEUTICALS, INC. ($ADIL) on April 07, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 7, 2026 | ADIAL PHARMACEUTICALS, INC. | $ADIL | Goodman Tony | Chief Operating Officer | A | Common Stock | 26510 | $0.00 | 26,523.0000 | 668,630 | 9999.99% | 3.96% |
| May 29, 2025 | ADIAL PHARMACEUTICALS, INC. | $ADIL | Goodman Tony | Chief Operating Officer | A | Stock Option (Right to Buy) | 94000 | $0.00 | 94,000.0000 | 6,539,760 | 9999.99% | 1.44% |
| March 25, 2024 | ADIAL PHARMACEUTICALS, INC. | $ADIL | Goodman Tony | Chief Operating Officer | A | Stock Option (Right to Buy) | 42000 | $0.00 | 42,000.0000 | 1,424,661 | 9999.99% | 2.95% |
| May 23, 2023 | ADIAL PHARMACEUTICALS, INC. | $ADIL | Goodman Tony | Director | A | Stock Option (Right to Buy) | 50000 | $0.00 | 50,000.0000 | 26,463,559 | 9999.99% | 0.19% |